• C.D.C. Warns the New Virus Variant Could Fuel Huge Spikes in Covid Cases - (01/16/21)
   
  
• ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe - (01/14/21)
   
  
• Five‐Year Lower Extremity Function is Associated with White Matter Abnormality in Older Adults - (01/14/21)
   
  
• COVID-19 death in people with HIV: interpret cautiously - Comment - (01/12/21)
   
  
• A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use - (01/11/21)
   
  
• AASLD: Efficacy and safety of subcutaneous semaglutide once-daily versus placebo in patients with nonalcoholic steatohepatitis
  Semaglutide Resolves NASH in Big Placebo-Controlled Trial - (01/07/21)
   
  
More HIV Articles...
 

• NIAID Renews Weill Cornell Medicine Grant for Advancing Prevention and Treatment Research for HIV - (12/04/20)
   
  
• ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement - (11/28/20)
   
  
More News Updates Articles...
 

• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• The impact of COVID-19 on hepatitis elimination - (01/15/21)
   
  
• SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination - (01/15/21)
   
  
• Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018...MSM - (01/11/21)
   
  
• State of the Hepatitis C Virus Care Cascade, USA, Gobally - (01/11/21)
   
  
• Increased case‐finding and uptake of direct‐acting antiviral treatment essential for micro‐elimination of hepatitis C among people living with HIV: a national record linkage study in Scotland, England, MSM - (01/11/21)
   
  
• New infections were associated with sharing chem‐sex drugs among MSM in Spain Among HIV+ has the potential to reseed the HCV epidemic and, consequently, preclude HCV elimination. - (01/11/21)
   
  
• HCV SCREENING AND LINKAGE TO CARE AT COMMUNITY HOSPITAL EMERGENCY DEPARTMENT: RETROSPECTIVE REVIEW OF PATIENT CHARACTERISTICS AND FUTURE IMPLICATIONS - (01/07/21)
   
  
More Hep C Articles...
 

• Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study - (04/20/21)
   
  
• AASLD: Infant Outcomes in HIV/Hepatitis B Co-Infected Women Initiating ART in the Promoting Maternal and Infant Survival Everywhere Study - (12/10/20)
   
  
• AASLD: Safety And HBV Efficacy Of Antiretroviral Therapy In Women With HIV And HBV In The Promoting Maternal And Infant Survival Everywhere Study (PROMISE) - (12/10/20)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.